Your browser doesn't support javascript.
loading
Heerlen polymorphism associated with type III protein S deficiency and factor V Leiden mutation in a Polish patient with deep vein thrombosis.
Wypasek, Ewa; Potaczek, Daniel P; Alhenc-Gelas, Martine; Undas, Anetta.
Affiliation
  • Wypasek E; aThe John Paul II Hospital bInstitute of Cardiology, Jagiellonian University Medical College, Kraków, Poland cHématologie biologique, AP-HP Hôpital Européen G. Pompidou, Paris, France.
Blood Coagul Fibrinolysis ; 25(1): 84-5, 2014 Jan.
Article in En | MEDLINE | ID: mdl-24365770
ABSTRACT
Protein S is one of the major natural anticoagulants. A missense serine 501 to proline (S501P) Heerlen polymorphism is associated with reduced levels of free protein S. Heerlen polymorphism, especially when combined with other thrombophilia risk factors, can lead to thromboembolic complications. To our knowledge, we report here the first Polish case associated with heterozygous Heerlen polymorphism resulting in type III protein S deficiency, detected in a 50-year-old man with several thrombotic episodes of deep and superficial veins and a highly positive thrombotic family history. The patient also had factor V Leiden mutation and persistently elevated anticardiolipin antibodies. It seems that increased risk of thrombotic complications could be explained in the patient by a synergy between the effects of Heerlen polymorphism, factor V Leiden heterozygous status and antiphospholipid syndrome.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Factor V / Blood Proteins / Protein S Deficiency / Venous Thrombosis Type of study: Risk_factors_studies Limits: Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2014 Type: Article

Full text: 1 Database: MEDLINE Main subject: Factor V / Blood Proteins / Protein S Deficiency / Venous Thrombosis Type of study: Risk_factors_studies Limits: Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2014 Type: Article